27.08.2021 • NewsEgypt

Egypt Plans $1.6 Billion Methanol/Ammonia Project

Helwan Fertilizers, Abu Qir Fertilizers and Al Ahly Capital Holding have agreed to set up a new company for producing methanol, ammonia and petrochemicals.

According to a statement by the Egyptian Cabinet, the new company will aim to meet local market demand for methanol and its derivatives, while exporting any surplus overseas.

Abu Qir Fertilizers and Helwan Fertilizers will each take a 35% stake in the company, while Al Ahly Capital Holding will own the remaining 30% share.

The first phase of the project will see $1.6 billion invested to build plants in the economic zone of the Suez Canal in Ain Sokhna, Egypt, for producing an estimated 1 million t/y methanol and 400,000 t/y ammonia.

Chairman of Abu Qir Fertilizer Saad Abu Al-Maaty said the project will be built in two stages and that all the necessary approvals for allocating land and securing natural gas feedstock have been obtained.

The partners added that a study has already confirmed the project’s economic and market feasibility.

Author: Elaine Burridge, Freelance Journalist

Helway Fertilizers, Abu Qir Fertilizers and Al Ahly Capital Holding will form a...
Helway Fertilizers, Abu Qir Fertilizers and Al Ahly Capital Holding will form a new company that will invest $1.6 billion to build plants in the economic zone of the Suez Canal in Ain Sokhna, Egypt, for producing an estimated 1 million t/y methanol and 400,000 t/y ammonia. (c) Pixabay

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.